Sgrùdaidhean clionaigeach Eczema ann an Florida
Tha 9 sgrùdaidhean airson Eczema a’ lorg phàirtichean aig làraichean ann an Florida.
Bailtean ann an Florida
Teacsa sgrùdaidh oifigeil (Beurla)
Ph 1a/1b Single Ascending Dose and Multiple Ascending Dose Study of ARQ-234
- Clinical Site 110, Miami
A’ fastadhÌre 1Fàilte do shaor-thoilich fhallain
Aoisean 18 gu 65 · Gach gnè · Air ùrachadh 29 Sult 2026 · NCT07453602Platform Study to Evaluate the Efficacy and Safety of Investigational Compound(s) in Patients With Moderate to Severe Atopic Dermatitis
- Novartis Investigative Site, Miami
- Novartis Investigative Site, St. Petersburg
A’ fastadhÌre 2
Aoisean 18 gu 100 · Gach gnè · Air ùrachadh 28 Sult 2026 · NCT06947993A Study of the Medicine Called Abrocitinib in Children 6 to Less Than 12 Years of Age With Moderate-to-Severe Eczema
- Solutions Through Advanced Research, Jacksonville
A’ fastadhÌre 3
Aoisean 6 gu 11 · Gach gnè · Air ùrachadh 25 Sult 2026 · NCT06807268A Long-term Study of the Medicine Called Abrocitinib in Children Aged 2 Years and Older With Moderate to Severe Eczema
- Solutions Through Advanced Research, Jacksonville
A’ fastadhÌre 3
Aoisean 2 gu 11 · Gach gnè · Air ùrachadh 25 Sult 2026 · NCT06807281A Study to Learn About Study Medicine Called PF-08049820 in People With Eczema
- Gsi Clinical Research, Margate
A’ fastadhÌre 2
Aoisean 18 gu 64 · Gach gnè · Air ùrachadh 25 Sult 2026 · NCT07216027A Study to Learn About the Study Medicine Called Tilrekimig in People With Moderate-to-Severe Eczema
- AllerVie Clinical Research, Panama City
- GCP Research , Global Clinical Professionals, St. Petersburg
A’ fastadhÌre 3
Aoisean 12 agus nas sine · Gach gnè · Air ùrachadh 4 Sult 2026 · NCT07765888A Phase 2b Study of the Effects of Camoteskimab in Adults With Moderate-to-Severe Atopic Dermatitis
- ABMED Clinical Research Corp., Cape Coral
- Skin Care Research, Hollywood
- Quality Care Clinical Research, Miami
- agus 4 a bharrachd
A’ fastadhÌre 2
Aoisean 18 gu 65 · Gach gnè · Air ùrachadh 28 Lùna 2026 · NCT07599813A Study to Evaluate the Efficacy and Safety of IMG-007 in Adult Participants With Moderate-to-Severe Atopic Dermatitis
- Inmagene Site 19, Ocala
- Inmagene Site 4, Tampa
A’ fastadhÌre 2
Aoisean 18 gu 74 · Gach gnè · Air ùrachadh 12 Lùna 2026 · NCT07037901A Study To Learn About Two Study Medicines (PF-07275315 And PF-07264660) In People Who Have Moderate To Severe Atopic Dermatitis
- Revival Research, Doral
- Floridian Research Institute Llc, Miami
- Global Health Research Center, Inc., Miami Lakes
- agus 4 a bharrachd
A’ fastadhÌre 2
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 4 Cèit 2026 · NCT05995964Bho ClinicalTrials.gov, dàta air a thogail 5 Dàmh 2026. Bidh gach sgrùdadh a’ suidheachadh a chuidi fhèin; bidh an sgioba sgrùdaidh a’ co-dhùnadh cò as urrainn pàirt a ghabhail.